Stock UniverseDerived research view · source repositories remain read-only

Mesoblast Limited (MESO)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
38.04
Global Rank
690
Market Cap
2.06B
Latest Close
13.95
RS Composite
-21.64% · G#2732

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-11.76%
3M
-11.99%
6M
-17.60%
1Y
21.73%
3Y
106.36%
5Y
-9.77%
10Y
-1.34%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 259.62K · 30-day average: 160.80K · Max drawdown over stored range: -95.66%

Research Snapshot

Relative Strength vs SPX

RS Composite-21.64%
20D RS-6.38%
60D RS-19.72%
120D RS-31.18%
Global RS Rank2732 · 18.57% percentile
Qualified+ RS Rank1060 · 15.74% percentile
Group ScopeQualified+
Primary RS Rank311 · 32.10% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank99 / 701
Primary Percentile86.02
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for MESO.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue7.43410.2117.5015.90217.198
Revenue Growth (YoY)-76.881%37.355%-26.54%-21.317%191.393%
Gross Profit-78.297-53.361-45.315-33.814-22.739
Operating Income-109.096-80.574-69.289-57.972-62.443
Free Cash Flow-102.396-65.939-63.533-48.729-50.634
Free Cash Flow Per Share-0.169-0.097-0.082-0.049-0.042
EPS (Diluted) GAAP-0.163306-0.1338-0.105299-0.089141-0.0846
EPS Growth
EPS Non-GAAP
Gross Margin100%100%100%100%-132.219%
Operating Margin-1467.528%-789.09%-923.73%-982.243%-363.083%
Profit Margin-1329.177%-894.594%-1091.708%-1490.274%-593.918%
Free Cash Flow Margin-1377.401%-645.764%-846.994%-825.635%-294.418%
Shares Outstanding (Diluted)605.064682.8614777.7191986.70291207.7931
Shares Change (YoY)14.417%12.858%13.891%26.871%22.407%

SEC Quarterly Fundamentals

No processed quarterly rows for MESO.